A review regarding the article ‘Impact of tricuspid regurgitation severity on mortality in pulmonary hypertension patients: A comprehensive analysis

ElsevierVolume 49, Issue 6, June 2024, 102535Current Problems in CardiologyAuthor links open overlay panel, Abstract

Pulmonary hypertension (PH) presents as a complex hemodynamic and pathophysiologic state present in many cardiovascular, respiratory, and systemic diseases. PH is considered to have a higher risk of cardiovascular events and mortality. The most common type of functional tricuspid regurgitation (TR) is associated with PH. Secondary TR, resulting not from intrinsic valvular pathology but from distortion of the valve apparatus due to right ventricular remodeling and dilation, is commonly seen in the setting of PH. It has been increasingly recognized as not merely a bystander but a significant contributor to the worsening of symptoms and decline in functional status. However, the extent to which TR impacts the clinical course and mortality in PH remains a subject of active investigation. The simultaneous presence of PH and secondary tricuspid regurgitation (STR) portends particularly poor outcomes. However, not all patients with PH develop significant TR, and the mechanisms and clinical implications underlying this phenomenon remain unclear. TR is a highly prevalent echocardiographic finding in the general population. Historically considered as the “forgotten valve disease” by clinicians and interventional cardiologists, TR has become a hot topic in cardiovascular interventions over recent years. If left untreated until severe, as often occurs, TR correlates with consistent morbidity and mortality, and a variety of surgical and percutaneous treatments have therefore been proposed. Mortality from isolated surgical repair of TR remains higher than that from surgery of any other valve insufficiency and a large number of patients are often deemed not eligible for surgical repair.

Section snippetsEthics approval and consent to participate

This is a review of a recently published article in Current Problems in Cardiology, no ethics approval and consent to participate was required.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable, please contact author for data requests.

Funding

Not applicable

CRediT authorship contribution statement

Juan Wu: Conceptualization, Data curation, Funding acquisition, Formal analysis, Writing – original draft. Yunfei Ling: Conceptualization, Data curation, Writing – original draft, Writing – review & editing.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

All authors contribute equally to this manuscript and are considered as first co-authors.

References (5)

There are more references available in the full text version of this article.

View full text

© 2024 Elsevier Inc. All rights reserved.

留言 (0)

沒有登入
gif